As of 2025-03-16, the EV/EBITDA ratio of Rapt Therapeutics Inc (RAPT) is 0.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAPT's latest enterprise value is -19.24 mil USD. RAPT's TTM EBITDA according to its financial statements is -107.73 mil USD. Dividing these 2 quantities gives us the above RAPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-03-12 | 0.14 |
| 2025-03-11 | 0.18 |
| 2025-03-10 | 0.26 |
| 2025-03-07 | 0.19 |
| 2025-03-06 | 0.20 |
| 2025-03-05 | 0.19 |
| 2025-03-04 | 0.23 |
| 2025-03-03 | 0.29 |
| 2025-02-28 | 0.18 |
| 2025-02-27 | 0.24 |
| 2025-02-26 | 0.14 |
| 2025-02-25 | 0.17 |
| 2025-02-24 | 0.13 |
| 2025-02-21 | 0.04 |
| 2025-02-20 | 0.03 |
| 2025-02-19 | 0.11 |
| 2025-02-18 | 0.11 |
| 2025-02-14 | 0.11 |
| 2025-02-13 | 0.12 |
| 2025-02-12 | 0.15 |
| 2025-02-11 | 0.14 |
| 2025-02-10 | 0.17 |
| 2025-02-07 | 0.15 |
| 2025-02-06 | 0.13 |
| 2025-02-05 | 0.09 |
| 2025-02-04 | 0.22 |
| 2025-02-03 | 0.18 |
| 2025-01-31 | 0.18 |
| 2025-01-30 | 0.18 |
| 2025-01-29 | 0.14 |
| 2025-01-28 | 0.13 |
| 2025-01-27 | 0.15 |
| 2025-01-24 | 0.13 |
| 2025-01-23 | 0.12 |
| 2025-01-22 | 0.08 |
| 2025-01-21 | 0.11 |
| 2025-01-17 | 0.11 |
| 2025-01-16 | 0.12 |
| 2025-01-15 | 0.11 |
| 2025-01-14 | 0.23 |
| 2025-01-13 | 0.09 |
| 2025-01-10 | -0.04 |
| 2025-01-08 | -0.20 |
| 2025-01-07 | -0.39 |
| 2025-01-06 | -0.53 |
| 2025-01-03 | -0.47 |
| 2025-01-02 | -0.42 |
| 2024-12-31 | -0.36 |
| 2024-12-30 | -0.41 |
| 2024-12-27 | -0.50 |